CRMD - NASDAQ

CorMedix Inc.

CRMD·NASDAQ

$8.23

+0.73%

HealthcareBiotechnology

CorMedix Inc., a biopharmaceutical company, focuses on developing and commercializing therapeutic products for the prevention and treatment of infectious and inflammatory diseases in the United States and internationally. Its lead product candidate is DefenCath/Neutrolin, a novel anti-infective solution for the reduction and prevention of catheter-related infections and thrombosis in patients requiring central venous catheters in clinical settings, such as hemodialysis, total parenteral nutrition, and oncology. The company was formerly known as Picton Holding Company, Inc. and changed its name to CorMedix, Inc. in January 2007. CorMedix Inc. was incorporated in 2006 and is based in Berkeley Heights, New Jersey.

Statements Value Model

At a Glance

Live Snapshot

Market Cap$645.66M

EPS2.2500

P/E Ratio3.66

Earnings Date08/06/2026

crmd

Other Current Assets

Last Annual Value

0.00

3-Year CAGR

5-Year CAGR

10-Year CAGR

Adjust for Inflation

CorMedix Inc. Competitors Analysis of Other Current Assets

CRMD · NASDAQ

Company	Other Current Assets	CAGR 3Y	CAGR 5Y	CAGR 10Y
CorMedix Inc. NASDAQ:CRMD	0.00	N/A	N/A	N/A
ProKidney Corp. NASDAQ:PROK	9.54M	919.4%	228.3%	N/A
Kura Oncology, Inc. NASDAQ:KURA	28.41M	49.4%	N/A	44.3%
EyePoint Pharmaceuticals, Inc. NASDAQ:EYPT	20.11M	171.1%	108.0%	N/A
Savara Inc. NASDAQ:SVRA	1.29M	66.2%	-3.0%	29.9%
Tango Therapeutics, Inc. NASDAQ:TNGX	10.62M	3.2%	79.7%	N/A
Septerna, Inc. NASDAQ:SEPN	9.52M	369.5%	N/A	N/A
Arbutus Biopharma Corporation NASDAQ:ABUS	1.24M	-33.7%	N/A	15.5%
Bicara Therapeutics Inc. Common Stock NASDAQ:BCAX	7.25M	317.0%	N/A	N/A
Palvella Therapeutics, Inc. NASDAQ:PVLA	1.00M	71.9%	-31.3%	N/A

CorMedix Inc. Fair Value Envelope

CRMD · NASDAQ

Our analysis suggests that CRMD has a fair value of HIDDEN per share in the Base Case projection. With shares currently trading at $8.23, this represents a potential HIDDEN relative to our calculated worth for CorMedix Inc..

HIDDEN

Intrinsic Value

Current Price: $8.23

Related Guides

Blog Categories

Continue your CRMD research with focused valuation guides.

Fundamentals

Decode statement quality and operating durability.

Accounting

Interpret line items with cleaner analytical framing.

Forecasting

Translate historical performance into forward scenarios.

Reference

Use practical frameworks for statement-led valuation.

Research Paths

Pick your next lens

Snapshot

Start with context, operating signals, and key market metrics.

Value Model

Stress test fair value across bear, base, and bull assumptions.

Statements

Validate revenue quality, margins, and balance sheet durability.

Earnings Call

Read management commentary and compare it with reported outcomes.

Dividends

Check payout sustainability and long-term distribution behavior.

Analyst Expectations

Review consensus spread and where estimate risk is concentrated.